Vanguard Group’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-6,993,901
| Closed | -$320M | – | 4126 |
|
|
2017
Q4 | $320M | Buy |
6,993,901
+278,148
| +4% | +$12.7M | 0.01% | 984 |
|
|
2017
Q3 | $301M | Buy |
6,715,753
+430,077
| +7% | +$19.3M | 0.01% | 993 |
|
|
2017
Q2 | $188M | Buy |
6,285,676
+131,864
| +2% | +$3.94M | 0.01% | 1267 |
|
|
2017
Q1 | $137M | Buy |
6,153,812
+303,912
| +5% | +$6.74M | 0.01% | 1477 |
|
|
2016
Q4 | $110M | Buy |
5,849,900
+215,963
| +4% | +$4.07M | 0.01% | 1563 |
|
|
2016
Q3 | $169M | Buy |
5,633,937
+162,287
| +3% | +$4.87M | 0.01% | 1225 |
|
|
2016
Q2 | $210M | Buy |
5,471,650
+707,140
| +15% | +$27.2M | 0.01% | 1027 |
|
|
2016
Q1 | $181M | Buy |
4,764,510
+149,155
| +3% | +$5.68M | 0.01% | 1078 |
|
|
2015
Q4 | $203M | Buy |
4,615,355
+238,110
| +5% | +$10.5M | 0.01% | 996 |
|
|
2015
Q3 | $178M | Buy |
4,377,245
+2,979,416
| +213% | +$121M | 0.01% | 1065 |
|
|
2015
Q2 | $74.5M | Buy |
1,397,829
+44,697
| +3% | +$2.38M | 0.01% | 1722 |
|
|
2015
Q1 | $82.1M | Buy |
1,353,132
+1,283,132
| +1,833% | +$77.8M | 0.01% | 1637 |
|
|
2014
Q4 | $3.66M | Buy |
+70,000
| New | +$3.66M | ﹤0.01% | 3046 |
|